J7185 Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.

Billable / valid for submission HCPCS Release 2026Q3

Short description: Xyntha inj

Version history

Release	Valid from	Valid to	Description	Billable
2026Q3	2026-07-01	current	Injection, factor viii (antihemophilic factor, recombinant) (xyntha), per i.u.	yes

J7100 Infusion, dextran 40, 500 ml
J7110 Infusion, dextran 75, 500 ml
J7120 Ringers lactate infusion, up to 1000 cc
J7121 5% dextrose in lactated ringers infusion, up to 1000 cc
J7131 Hypertonic saline solution, 1 ml
J7165 Injection, prothrombin complex concentrate, human-lans, per i.u. of factor ix activity
J7168 Prothrombin complex concentrate (human), kcentra, per i.u. of factor ix activity
J7169 Injection, coagulation factor xa (recombinant), inactivated-zhzo (andexxa), 10 mg
J7170 Injection, emicizumab-kxwh, 0.5 mg
J7171 Injection, adamts13, recombinant-krhn, 10 iu
J7172 Injection, marstacimab-hncq, 0.5 mg
J7173 Injection, concizumab-mtci, 0.5 mg
J7174 Injection, fitusiran, 0.04 mg
J7175 Injection, factor x, (human), 1 i.u.
J7176 Injection, human fibrinogen - chmt (fesilty), 1 mg
J7177 Injection, human fibrinogen concentrate (fibryga), 1 mg
J7178 Injection, human fibrinogen concentrate, not otherwise specified, 1 mg
J7179 Injection, von willebrand factor (recombinant), (vonvendi), 1 i.u. vwf:rco
J7180 Injection, factor xiii (antihemophilic factor, human), 1 i.u.
J7181 Injection, factor xiii a-subunit, (recombinant), per iu